The Relationship between Different Assays for Detection and Quantification of Amyloid Beta 42 in Human Cerebrospinal Fluid

@inproceedings{Ellis2012TheRB,
  title={The Relationship between Different Assays for Detection and Quantification of Amyloid Beta 42 in Human Cerebrospinal Fluid},
  author={Teresa A. Ellis and Jinhe Li and David Leblond and Jeffrey F. Waring},
  booktitle={International journal of Alzheimer's disease},
  year={2012}
}
Alzheimer's disease (AD), which is characterized by a degeneration of neurons and their synapses, is one of the most common forms of dementia. CSF levels of amyloid β(42) (Aβ(42)) have been recognized as a strong candidate to serve as an AD biomarker. There are a number of commercial assays that are routinely employed for measuring Aβ(42); however, these… CONTINUE READING